Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Cross-talk between Lysine-Modifying Enzymes Controls Site-Specific DNA Amplifications.

Mishra S, Van Rechem C, Pal S, Clarke TL, Chakraborty D, Mahan SD, Black JC, Lawrence MS, Daniels DL, Whetstine JR.

Cell. 2018 Aug 9;174(4):803-817.e16. doi: 10.1016/j.cell.2018.06.018. Epub 2018 Jul 26.

PMID:
30057114
2.

Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation.

Meier JC, Tallant C, Fedorov O, Witwicka H, Hwang SY, van Stiphout RG, Lambert JP, Rogers C, Yapp C, Gerstenberger BS, Fedele V, Savitsky P, Heidenreich D, Daniels DL, Owen DR, Fish PV, Igoe NM, Bayle ED, Haendler B, Oppermann UCT, Buffa F, Brennan PE, Müller S, Gingras AC, Odgren PR, Birnbaum MJ, Knapp S.

ACS Chem Biol. 2017 Oct 20;12(10):2619-2630. doi: 10.1021/acschembio.7b00481. Epub 2017 Sep 12.

3.

Target Identification Using Cell Permeable and Cleavable Chloroalkane Derivatized Small Molecules.

Mendez-Johnson JL, Daniels DL, Urh M, Friedman Ohana R.

Methods Mol Biol. 2017;1647:91-108. doi: 10.1007/978-1-4939-7201-2_6.

PMID:
28808997
4.

Potent and selective bivalent inhibitors of BET bromodomains.

Waring MJ, Chen H, Rabow AA, Walker G, Bobby R, Boiko S, Bradbury RH, Callis R, Clark E, Dale I, Daniels DL, Dulak A, Flavell L, Holdgate G, Jowitt TA, Kikhney A, McAlister M, Méndez J, Ogg D, Patel J, Petteruti P, Robb GR, Robers MB, Saif S, Stratton N, Svergun DI, Wang W, Whittaker D, Wilson DM, Yao Y.

Nat Chem Biol. 2016 Dec;12(12):1097-1104. doi: 10.1038/nchembio.2210. Epub 2016 Oct 24.

PMID:
27775716
5.

SONAR Discovers RNA-Binding Proteins from Analysis of Large-Scale Protein-Protein Interactomes.

Brannan KW, Jin W, Huelga SC, Banks CA, Gilmore JM, Florens L, Washburn MP, Van Nostrand EL, Pratt GA, Schwinn MK, Daniels DL, Yeo GW.

Mol Cell. 2016 Oct 20;64(2):282-293. doi: 10.1016/j.molcel.2016.09.003. Epub 2016 Oct 6.

6.

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.

Clark PG, Vieira LC, Tallant C, Fedorov O, Singleton DC, Rogers CM, Monteiro OP, Bennett JM, Baronio R, Müller S, Daniels DL, Méndez J, Knapp S, Brennan PE, Dixon DJ.

Angew Chem Weinheim Bergstr Ger. 2015 May 18;127(21):6315-6319. Epub 2015 Apr 13.

7.

The TIP60 Complex Is a Conserved Coactivator of HIF1A.

Perez-Perri JI, Dengler VL, Audetat KA, Pandey A, Bonner EA, Urh M, Mendez J, Daniels DL, Wappner P, Galbraith MD, Espinosa JM.

Cell Rep. 2016 Jun 28;16(1):37-47. doi: 10.1016/j.celrep.2016.05.082. Epub 2016 Jun 16.

8.

Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes.

McGrath JP, Williamson KE, Balasubramanian S, Odate S, Arora S, Hatton C, Edwards TM, O'Brien T, Magnuson S, Stokoe D, Daniels DL, Bryant BM, Trojer P.

Cancer Res. 2016 Apr 1;76(7):1975-88. doi: 10.1158/0008-5472.CAN-15-2333. Epub 2016 Feb 2.

9.

Target engagement and drug residence time can be observed in living cells with BRET.

Robers MB, Dart ML, Woodroofe CC, Zimprich CA, Kirkland TA, Machleidt T, Kupcho KR, Levin S, Hartnett JR, Zimmerman K, Niles AL, Ohana RF, Daniels DL, Slater M, Wood MG, Cong M, Cheng YQ, Wood KV.

Nat Commun. 2015 Dec 3;6:10091. doi: 10.1038/ncomms10091.

10.

Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy.

Picaud S, Fedorov O, Thanasopoulou A, Leonards K, Jones K, Meier J, Olzscha H, Monteiro O, Martin S, Philpott M, Tumber A, Filippakopoulos P, Yapp C, Wells C, Che KH, Bannister A, Robson S, Kumar U, Parr N, Lee K, Lugo D, Jeffrey P, Taylor S, Vecellio ML, Bountra C, Brennan PE, O'Mahony A, Velichko S, Müller S, Hay D, Daniels DL, Urh M, La Thangue NB, Kouzarides T, Prinjha R, Schwaller J, Knapp S.

Cancer Res. 2015 Dec 1;75(23):5106-5119. doi: 10.1158/0008-5472.CAN-15-0236. Epub 2015 Nov 9.

11.

NanoBRET--A Novel BRET Platform for the Analysis of Protein-Protein Interactions.

Machleidt T, Woodroofe CC, Schwinn MK, Méndez J, Robers MB, Zimmerman K, Otto P, Daniels DL, Kirkland TA, Wood KV.

ACS Chem Biol. 2015 Aug 21;10(8):1797-804. doi: 10.1021/acschembio.5b00143. Epub 2015 Jun 9.

12.

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor.

Clark PG, Vieira LC, Tallant C, Fedorov O, Singleton DC, Rogers CM, Monteiro OP, Bennett JM, Baronio R, Müller S, Daniels DL, Méndez J, Knapp S, Brennan PE, Dixon DJ.

Angew Chem Int Ed Engl. 2015 May 18;54(21):6217-21. doi: 10.1002/anie.201501394. Epub 2015 Apr 13.

13.

9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain.

Picaud S, Strocchia M, Terracciano S, Lauro G, Mendez J, Daniels DL, Riccio R, Bifulco G, Bruno I, Filippakopoulos P.

J Med Chem. 2015 Mar 26;58(6):2718-36. doi: 10.1021/jm501893k. Epub 2015 Mar 5.

14.

Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer.

Bowman BM, Sebolt KA, Hoff BA, Boes JL, Daniels DL, Heist KA, Galbán CJ, Patel RM, Zhang J, Beer DG, Ross BD, Rehemtulla A, Galbán S.

Sci Signal. 2015 Jan 27;8(361):ra9. doi: 10.1126/scisignal.2005607. Erratum in: Sci Signal. 2015 Mar 17;8(368):er3.

15.

EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation.

Bradley WD, Arora S, Busby J, Balasubramanian S, Gehling VS, Nasveschuk CG, Vaswani RG, Yuan CC, Hatton C, Zhao F, Williamson KE, Iyer P, Méndez J, Campbell R, Cantone N, Garapaty-Rao S, Audia JE, Cook AS, Dakin LA, Albrecht BK, Harmange JC, Daniels DL, Cummings RT, Bryant BM, Normant E, Trojer P.

Chem Biol. 2014 Nov 20;21(11):1463-75. doi: 10.1016/j.chembiol.2014.09.017.

16.

Discovering protein interactions and characterizing protein function using HaloTag technology.

Daniels DL, Méndez J, Benink H, Niles A, Murphy N, Ford M, Jones R, Amunugama R, Allen D, Urh M.

J Vis Exp. 2014 Jul 12;(89). doi: 10.3791/51553.

17.

Synthesis of 3,5-isoxazolidinediones and 1H-2,3-benzoxazine-1,4(3H)-diones from aliphatic oximes and dicarboxylic acid chlorides.

Izydore RA, Jones JT, Mogesa B, Swain IN, Davis-Ward RG, Daniels DL, Kpakima FF, Spaulding-Phifer ST 2nd.

J Org Chem. 2014 Apr 4;79(7):2874-82. doi: 10.1021/jo402708j. Epub 2014 Mar 21.

18.

KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors.

Black JC, Manning AL, Van Rechem C, Kim J, Ladd B, Cho J, Pineda CM, Murphy N, Daniels DL, Montagna C, Lewis PW, Glass K, Allis CD, Dyson NJ, Getz G, Whetstine JR.

Cell. 2013 Aug 1;154(3):541-55. doi: 10.1016/j.cell.2013.06.051. Epub 2013 Jul 18.

19.

structural Studies of Wnts and identification of an LRP6 binding site.

Chu ML, Ahn VE, Choi HJ, Daniels DL, Nusse R, Weis WI.

Structure. 2013 Jul 2;21(7):1235-42. doi: 10.1016/j.str.2013.05.006. Epub 2013 Jun 20.

20.

HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia.

Galbraith MD, Allen MA, Bensard CL, Wang X, Schwinn MK, Qin B, Long HW, Daniels DL, Hahn WC, Dowell RD, Espinosa JM.

Cell. 2013 Jun 6;153(6):1327-39. doi: 10.1016/j.cell.2013.04.048.

21.

Isolation of intracellular protein--DNA complexes using HaloCHIP, an antibody-free alternative to chromatin immunoprecipitation.

Daniels DL, Urh M.

Methods Mol Biol. 2013;977:111-24. doi: 10.1007/978-1-62703-284-1_9.

PMID:
23436357
22.

TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.

Deplus R, Delatte B, Schwinn MK, Defrance M, Méndez J, Murphy N, Dawson MA, Volkmar M, Putmans P, Calonne E, Shih AH, Levine RL, Bernard O, Mercher T, Solary E, Urh M, Daniels DL, Fuks F.

EMBO J. 2013 Mar 6;32(5):645-55. doi: 10.1038/emboj.2012.357. Epub 2013 Jan 25.

23.

Development of a dehalogenase-based protein fusion tag capable of rapid, selective and covalent attachment to customizable ligands.

Encell LP, Friedman Ohana R, Zimmerman K, Otto P, Vidugiris G, Wood MG, Los GV, McDougall MG, Zimprich C, Karassina N, Learish RD, Hurst R, Hartnett J, Wheeler S, Stecha P, English J, Zhao K, Mendez J, Benink HA, Murphy N, Daniels DL, Slater MR, Urh M, Darzins A, Klaubert DH, Bulleit RF, Wood KV.

Curr Chem Genomics. 2012;6:55-71. doi: 10.2174/1875397301206010055. Epub 2012 Oct 5.

24.

Examining the complexity of human RNA polymerase complexes using HaloTag technology coupled to label free quantitative proteomics.

Daniels DL, Méndez J, Mosley AL, Ramisetty SR, Murphy N, Benink H, Wood KV, Urh M, Washburn MP.

J Proteome Res. 2012 Feb 3;11(2):564-75. doi: 10.1021/pr200459c. Epub 2012 Jan 3.

PMID:
22149079
25.

The influence of gender on auditory and language cortical activation patterns: preliminary data.

Kocak M, Ulmer JL, Biswal BB, Aralasmak A, Daniels DL, Mark LP.

AJNR Am J Neuroradiol. 2005 Oct;26(9):2248-55.

26.

Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.

Daniels DL, Weis WI.

Nat Struct Mol Biol. 2005 Apr;12(4):364-71. Epub 2005 Mar 13.

PMID:
15768032
27.

SWGDAM developmental validation of a 19-locus Y-STR system for forensic casework.

Daniels DL, Hall AM, Ballantyne J.

J Forensic Sci. 2004 Jul;49(4):668-83.

PMID:
15317180
28.

The frontal sinus drainage pathway and related structures.

Daniels DL, Mafee MF, Smith MM, Smith TL, Naidich TP, Brown WD, Bolger WE, Mark LP, Ulmer JL, Hacein-Bey L, Strottmann JM.

AJNR Am J Neuroradiol. 2003 Sep;24(8):1618-27. No abstract available.

29.

Intensity-dependent activation of the primary auditory cortex in functional magnetic resonance imaging.

Lasota KJ, Ulmer JL, Firszt JB, Biswal BB, Daniels DL, Prost RW.

J Comput Assist Tomogr. 2003 Mar-Apr;27(2):213-8.

PMID:
12703014
31.

The ascending pharyngeal artery: branches, anastomoses, and clinical significance.

Hacein-Bey L, Daniels DL, Ulmer JL, Mark LP, Smith MM, Strottmann JM, Brown D, Meyer GA, Wackym PA.

AJNR Am J Neuroradiol. 2002 Aug;23(7):1246-56. Review.

32.

Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging.

Mark LP, Prost RW, Ulmer JL, Smith MM, Daniels DL, Strottmann JM, Brown WD, Hacein-Bey L.

AJNR Am J Neuroradiol. 2001 Nov-Dec;22(10):1813-24. Review. No abstract available.

33.

beta-catenin: molecular plasticity and drug design.

Daniels DL, Eklof Spink K, Weis WI.

Trends Biochem Sci. 2001 Nov;26(11):672-8. Review.

PMID:
11701326
34.

Effects of benzohydroxamic acids on L1210 lymphoid leukemia cell nucleic acid metabolism.

Hall IH, Taylor K, Izydore RA, Daniels DL.

Pharmazie. 1998 Nov;53(11):794-9. No abstract available.

PMID:
9853360
35.

Abnormal cerebral activation associated with a motor task in Tourette syndrome.

Biswal B, Ulmer JL, Krippendorf RL, Harsch HH, Daniels DL, Hyde JS, Haughton VM.

AJNR Am J Neuroradiol. 1998 Sep;19(8):1509-12.

36.

Osseous anatomy of the pterygopalatine fossa.

Daniels DL, Mark LP, Ulmer JL, Mafee MF, McDaniel J, Shah NC, Erickson S, Sether LA, Jaradeh SS.

AJNR Am J Neuroradiol. 1998 Sep;19(8):1423-32. No abstract available.

37.

Crystal structure of the hCASK PDZ domain reveals the structural basis of class II PDZ domain target recognition.

Daniels DL, Cohen AR, Anderson JM, Brünger AT.

Nat Struct Biol. 1998 Apr;5(4):317-25.

PMID:
9546224
38.

Understanding the brain stem.

Daniels DL, Mark LP, Ulmer J, Maas EF, Borne JA, Calderwood GW.

Neuroimaging Clin N Am. 1998 Feb;8(1):55-68. Review.

PMID:
9449753
39.

The elbow joint: osseous and ligamentous structures.

Daniels DL, Mallisee TA, Erickson SJ, Boynton MD, Carrera GF.

Radiographics. 1998 Jan-Feb;18(1):229-36. No abstract available.

PMID:
9460127
40.

Cortical activation response to acoustic echo planar scanner noise.

Ulmer JL, Biswal BB, Yetkin FZ, Mark LP, Mathews VP, Prost RW, Estkowski LD, McAuliffe TL, Haughton VM, Daniels DL.

J Comput Assist Tomogr. 1998 Jan-Feb;22(1):111-9.

PMID:
9448773
41.

Functional MR activation correlated with intraoperative cortical mapping.

Yetkin FZ, Mueller WM, Morris GL, McAuliffe TL, Ulmer JL, Cox RW, Daniels DL, Haughton VM.

AJNR Am J Neuroradiol. 1997 Aug;18(7):1311-5.

42.

Normal MR imaging anatomy of the elbow.

Mallisee TA, Boynton MD, Erickson SJ, Daniels DL.

Magn Reson Imaging Clin N Am. 1997 Aug;5(3):451-79. Review.

PMID:
9219713
43.

MR imaging of lumbar spondylolysis: the importance of ancillary observations.

Ulmer JL, Mathews VP, Elster AD, Mark LP, Daniels DL, Mueller W.

AJR Am J Roentgenol. 1997 Jul;169(1):233-9.

PMID:
9207531
44.

The endolymphatic duct and sac.

Lo WW, Daniels DL, Chakeres DW, Linthicum FH Jr, Ulmer JL, Mark LP, Swartz JD.

AJNR Am J Neuroradiol. 1997 May;18(5):881-7. Review. No abstract available.

45.

Functional MR of the primary auditory cortex: an analysis of pure tone activation and tone discrimination.

Strainer JC, Ulmer JL, Yetkin FZ, Haughton VM, Daniels DL, Millen SJ.

AJNR Am J Neuroradiol. 1997 Apr;18(4):601-10.

46.

Synthesis and cytotoxic action of 3,5-isoxazolidinediones and 2-isoxazolin-5-ones in murine and human tumors.

Hall IH, Izydore RA, Zhou X, Daniels DL, Woodard T, Debnath ML, Tse E, Muhammad RA.

Arch Pharm (Weinheim). 1997 Mar;330(3):67-73.

PMID:
9167449
47.

Hearing, II: the retrocochlear auditory pathway.

Swartz JD, Daniels DL, Harnsberger HR, Ulmer JL, Shaffer KA, Mark LP.

AJNR Am J Neuroradiol. 1996 Sep;17(8):1479-81. No abstract available.

48.

Anatomic Moment. Hearing, I: The cochlea.

Daniels DL, Swartz JD, Harnsberger HR, Ulmer JL, Shaffer KA, Mark L.

AJNR Am J Neuroradiol. 1996 Aug;17(7):1237-41. No abstract available.

49.

Balance and equilibrium, II: The retrovestibular neural pathway.

Swartz JD, Daniels DL, Harnsberger HR, Ulmer JL, Harvey S, Shaffer KA, Mark L.

AJNR Am J Neuroradiol. 1996 Jun-Jul;17(6):1187-90. Review. No abstract available.

50.

Supplemental Content

Loading ...
Support Center